INSIGHTS ON UPSTREAM MANUFACTURING
-
![DNA Helix, Futuristic Digital Interface, genetics, molecular biology, gene editing-GettyImages-2221747428]( "Turning Gene Therapies Into Patient Reality: Large Scale Cost-Effective AAV Production")
Turning Gene Therapies Into Patient Reality: Large Scale Cost-Effective AAV ProductionUnderstanding how upstream control, downstream efficiency, and process robustness scale together is essential for protecting supply and expanding patient access.
-
![GettyImages-1435246294-assay-cell-culture-pipette-hands]( "The Science Fueling Cell Culture Optimization For Biologic Therapies")
The Science Fueling Cell Culture Optimization For Biologic TherapiesBoost mAb titers by over 60% with an optimized intensified fed-batch process, no new equipment required. See the data.
-
![GettyImages-675822772-scientist-holding-book-with-bioreactor]( "In Vivo Manufacturing: When The Body Becomes The Bioreactor")
In Vivo Manufacturing: When The Body Becomes The BioreactorBreakthrough therapies are reshaping medicine, but manufacturing complexity is holding them back. Discover how rethinking production and delivery could expand reach and improve patient experience.
-
![Magnetic beads in action]( "The Body As A Bioreactor – The Vision")
The Body As A Bioreactor – The VisionAs cell therapy manufacturing reaches its limits, a new model is emerging. Learn how in vivo approaches that harness the body as a bioreactor could expand access and reshape the future.
-
Enabling A Four-Fold Increase In Titer For mAb Manufacturing5/14/2026
A platform-based upstream strategy increased monoclonal antibody titers fourfold, improving yield, efficiency, and scalability via optimized clones, process design, and rapid scale-up.
-
Unlock The Potential Of GPEx® Lightning: Accelerate Your HEK Cell Line Development5/8/2026
Cut HEK cell line development to four months with 30% higher titers. GPEx® Lightning delivers faster, scalable biologics manufacturing. Access the full summary now.
-
Comprehensive Bioprocess Control: Substrate, Metabolite And Product Analysis5/6/2026
Explore how multi-parameter bioprocess analyzers support monitoring of 30+ bioprocess parameters across mammalian and microbial systems to optimize yield and product quality.
-
Rapid Selection Of High-Performance CHO Basal And Feed Media5/5/2026
A CHO-S bispecific antibody program needed a better basal and feed media combination. Learn how the screening of 180 conditions in 12 weeks identified one that delivered 38% higher titers.
UPSTREAM MANUFACTURING SOLUTIONS
-
![pharma-manufacturing-GettyImages-2196233628]( "Quality At Scale: Biologics Development And Manufacturing")
886+ biologics batches. 12 commercial molecules. Proven scale-up from IND to commercialization. See how a global CDMO network protects quality at every stage.
-
![Bioreactor for cell culture-GettyImages-517653054]( "A Data Driven Approach To Mammalian Scale-Up And Transfer")
Mammalian scale‑up is vulnerable to subtle changes. Discover a mechanistic, data‑driven approach that uses cellular kinetics, modeling, and scaled‑down validation to help reduce transfer risk.
-
![biologics-GettyImages-2243791279]( "Raising The Bar On What's Achievable In Continuous Manufacturing")
Integrated perfusion and downstream processing reduce timelines without compromising quality, showing how continuous manufacturing is elevating yield, efficiency, and long-term stability.
-
![GettyImages-2184219690-antibody-biologic]( "Meet MaruXTM: Setting The Standard For End-To-End Continuous Biomanufacturing")
Continuous biomanufacturing boosts speed, flexibility, and control. Modular automation, intensified processing, and streamlined workflows drive productivity and consistent quality.
-
![GettyImages-1626470215-cluster-cells-stem-cells-blue]( "Cell Therapy Selection Guide: Connected From Activation To Expansion")
Active bead release gives manufacturers precise control over T cell isolation timing, phenotype preservation, and workflow efficiency, eliminating multi-day passive dissociation delays.
